+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Huntington's Disease Treatment Market Analysis & Forecast 2024-2034: Market By Drug; By Treatment; By End-user; and By Region

  • PDF Icon

    Report

  • 145 Pages
  • October 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5890311
The global Huntington’s disease treatment market size was estimated to be USD 0.472 billion in 2023 and is expected to reach at USD 5.08 billion by 2034 with a CAGR of 24.13% during the forecast period 2024-2034. Rising prevalence of Huntington’s Disease (HD), robust product pipeline for disease-modifying treatments, increasing launch of novel products, surge in product approvals by regulatory bodies, growing research & development activities, surge in number of clinical trials, increasing focus on development of innovative medications for Huntington's disease by major market players are some of the key factors boosting the market growth.

Increasing focus on development of innovative medications for Huntington's disease by major market players is predicted to boost the market growth during the forecast period. Numerous research institutions and governmental entities are offering research funding and technological assistance to expedite the progress of candidate pipelines. For instance, in May 2023, The phase 3 clinical trial of Neurocrine Biosciences' medication valbenazine has demonstrated substantial advancements in the successful management of chorea linked to Huntington's disease.

By drug, tetrabenazine was the highest revenue-grossing segment in the global Huntington’s disease treatment market in 2023 owing to increasing adoption rate due to availability of its generic version and increasing research & development activities for the formulation of innovative treatment for Huntington’s disease. Additionally, deutetrabenzine is predicted to grow at fastest CAGR during the forecast period owing to the negative side effects associated with the medication and rising approvals of novel medications by regulatory bodies. For instance, in February 2023, Teva Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries Ltd. based in the U.S., declared that the U.S. Food and Drug Administration (FDA) has granted approval for AUSTEDOXR (deutetrabenazine) extended-release tablets. This novel once-daily version is intended for use in adults to treat tardive dyskinesia (TD) as well as the chorea linked to Huntington's disease (HD).

By treatment, symptomatic treatment was the highest revenue-grossing segment in the global Huntington’s disease treatment market in 2023 owing to the accessibility of symptom treatment products and their patent protection, increasing research & development activities, rising approvals by regulatory bodies, surge in number of clinical trial procedures. For instance, in June 2023, uniQure N.V. has reported encouraging interim results, which include a follow-up period of up to 24 months, from the ongoing Phase I/II clinical study of AMT-130 for Huntington's disease treatment, involving 26 enrolled patients in the United States. Additionally, disease-modifying therapies is predicted to grow at fastest CAGR during the forecast period owing to rising research & development activities for disease-modifying therapy, increasing demand for gene therapy & stem cell therapy, surge in initiatives by governmental organizations, such as the U.S. FDA's Fast Track Designation for speeding the registration process.

By end-user, hospital pharmacy was the highest revenue-grossing segment in the global Huntington’s disease treatment market in 2023 owing to increasing healthcare infrastructure, access to a large patient population, ties with pharmaceutical stakeholders, & multidisciplinary approach to therapy, and rising approvals of novel drugs by regulatory bodies. For instance, in August 2023, The Food and Drug Administration (FDA) has given its approval for Ingrezza® (valbenazine) to be used in the treatment of chorea linked to Huntington's disease in adults. Additionally, e-commerce is predicted to grow at fastest CAGR during the forecast period owing to the growing usage of smartphone & internet, the simplicity of buying prescription drugs online and the expansion of e-commerce services internationally.

North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of the disease, increasing technological advancements, rising healthcare expenditure, surge in government initiatives, growing awareness regarding treatment products for Huntington’s disease among patients, and increasing partnership & collaborations within market players. For instance, in May 2023, The Huntington's Disease Society of America (HDSA) and RARE-X, a patient-driven data collection platform under Global Genes, have partnered to create a robust natural history study aimed at expediting knowledge acquisition. This initiative, known as the Huntington's Disease Data Collection Initiative (HD-DCI), empowers individuals with Huntington's disease (HD) to enhance the sharing of their data, thereby expediting the advancement of HD treatments. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the higher product adoption, rising prevalence of Huntington’s disease, increasing number of efforts by governments being undertaken to enhance people’s, and growing collaborations within market players. For instance, in March 2023, UCB, an international biopharmaceutical firm, and Aitia, a pioneer in using Causal AI and 'Digital Twins' for drug discovery, have revealed an early-stage partnership in drug discovery. This collaboration is primarily centered on identifying and confirming new drug targets and potential drug candidates for Huntington's disease. The objective is to validate fresh drug targets that are directly associated with clinical outcomes in Huntington's disease.

Segmentation: Huntington’s Disease Treatment Market Report 2022 - 2033

Huntington’s Disease Treatment Market Analysis & Forecast by Drug 2023 - 2034 (Revenue USD Bn)

  • Deutetrabenzine
  • Tetrabenazine
  • Others

Huntington’s Disease Treatment Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)

  • Disease-modifying Therapies
  • Symptomatic Treatment

Huntington’s Disease Treatment Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • E-commerce
  • Hospital Pharmacy
  • Retail Pharmacy

Huntington’s Disease Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Huntington’s Disease Treatment Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Huntington’s Disease Treatment Market: Drug Estimates & Trend Analysis
7.1. Drug Segment Opportunity Analysis
7.2. Deutetrabenzine
7.2.1. Deutetrabenzine Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Tetrabenazine
7.3.1. Tetrabenazine Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Others
7.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Huntington’s Disease Treatment Market: Treatment Estimates & Trend Analysis
8.1. Treatment Segment Opportunity Analysis
8.2. Disease-modifying Therapies
8.2.1. Disease-modifying Therapies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Symptomatic Treatment
8.3.1. Symptomatic Treatment Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Huntington’s Disease Treatment Market: End-user Estimates & Trend Analysis
9.1. End-user Segment Opportunity Analysis
9.2. E-commerce
9.2.1. E-commerce Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Hospital Pharmacy
9.3.1. Hospital Pharmacy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Retail Pharmacy
9.4.1. Retail Pharmacy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Huntington’s Disease Treatment Market
11.1. North America Huntington’s Disease Treatment Market
11.1.1. North America Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Huntington’s Disease Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
11.1.4. North America Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.1.5. North America Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Huntington’s Disease Treatment Market
11.2.1. U.S. Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Huntington’s Disease Treatment Market
11.3.1. Canada Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Europe Global Huntington’s Disease Treatment Market
12.1. Europe Global Huntington’s Disease Treatment Market
12.1.1. Europe Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Huntington’s Disease Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Huntington’s Disease Treatment Market
12.2.1. Germany Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. UK Global Huntington’s Disease Treatment Market
12.3.1. UK Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
12.3.3. UK Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.3.4. UK Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. France Global Huntington’s Disease Treatment Market
12.4.1. France Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
12.4.3. France Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.4.4. France Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Huntington’s Disease Treatment Market
12.5.1. Spain Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Huntington’s Disease Treatment Market
12.6.1. Italy Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Huntington’s Disease Treatment Market
12.7.1. Rest of Europe Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Huntington’s Disease Treatment Market
13.1. Asia Pacific Global Huntington’s Disease Treatment Market
13.1.1. Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Huntington’s Disease Treatment Market
13.2.1. Japan Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. China Global Huntington’s Disease Treatment Market
13.3.1. China Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
13.3.3. China Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.3.4. China Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. India Global Huntington’s Disease Treatment Market
13.4.1. India Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
13.4.3. India Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.4.4. India Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Huntington’s Disease Treatment Market
13.5.1. South Korea Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Huntington’s Disease Treatment Market
13.6.1. Australia Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Huntington’s Disease Treatment Market
13.7.1. Rest of Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Latin America Global Huntington’s Disease Treatment Market
14.1. Latin America Global Huntington’s Disease Treatment Market
14.1.1. Latin America Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Huntington’s Disease Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Huntington’s Disease Treatment Market
14.2.1. Brazil Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Huntington’s Disease Treatment Market
14.3.1. Mexico Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Huntington’s Disease Treatment Market
14.4.1. Argentina Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Huntington’s Disease Treatment Market
14.5.1. Rest of Latin America Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. MEA Global Huntington’s Disease Treatment Market
15.1. MEA Global Huntington’s Disease Treatment Market
15.1.1. MEA Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Huntington’s Disease Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Huntington’s Disease Treatment Market
15.2.1. GCC Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Huntington’s Disease Treatment Market
15.3.1. South Africa Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Huntington’s Disease Treatment Market
15.4.1. Rest of MEA Huntington’s Disease Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Huntington’s Disease Treatment Market Size and Forecast, By Drug, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Huntington’s Disease Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Huntington’s Disease Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Novartis AG
17.2. Lupin
17.3. AOP Health
17.4. H. Lundbeck A/S
17.5. Vaccinex, Inc
17.6. Teva Pharmaceutical Industries Ltd.
17.7. Prilenia Therapeutics
17.8. Bausch Health Companies Inc.
17.9. Medesis Pharma SA
17.10. Hetero
17.11. Neurocrine Biosciences
17.12. Hikma Pharmaceuticals PLC
17.13. som biotech
17.14. Dr. Reddy’s Laboratories Ltd.
17.15. UniQure
17.16. Sun Pharmaceutical Industries Ltd.
17.17. Mitochon Pharmaceuticals
17.18. Annexon Biosciences
17.19. PTC Therapeutics
17.20. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • Novartis AG
  • Lupin
  • AOP Health
  • H. Lundbeck A/S
  • Vaccinex Inc
  • Teva Pharmaceutical Industries Ltd.
  • Prilenia Therapeutics
  • Bausch Health Companies Inc.
  • Medesis Pharma SA
  • Hetero
  • Neurocrine Biosciences
  • Hikma Pharmaceuticals PLC
  • som biotech
  • Dr. Reddy’s Laboratories Ltd.
  • UniQure
  • Sun Pharmaceutical Industries Ltd.
  • Mitochon Pharmaceuticals
  • Annexon Biosciences
  • PTC Therapeutics

Table Information